CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+6.25%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.4B
AUM Growth
+$904M
(+5.5%)
Cap. Flow
+$91.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
731
New
36
Increased
329
Reduced
218
Closed
40
Top Buys
| 1 |
Amgen
AMGN
|
$65.4M |
| 2 |
Amazon
AMZN
|
$57.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$54.5M |
| 4 |
BioNTech
BNTX
|
$41.3M |
| 5 |
Advanced Micro Devices
AMD
|
$40.5M |
Top Sells
| 1 |
Lam Research
LRCX
|
$122M |
| 2 |
Thermo Fisher Scientific
TMO
|
$63.5M |
| 3 |
Applied Materials
AMAT
|
$43.1M |
| 4 |
Nu Holdings
NU
|
$36.4M |
| 5 |
Incyte
INCY
|
$33.7M |
Sector Composition
| 1 | Technology | 31.8% |
| 2 | Healthcare | 28.54% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Costco
COST
$424B
| $48.5M | 0.28% |
54,686
-24,871
| -31% | -$22M |
|
77
Keysight
KEYS
$28.7B
| $48.1M | 0.28% |
302,404
-2,377
| -0.8% | -$378K |
|
78
Otis Worldwide
OTIS
$33.9B
| $47.4M | 0.27% |
456,100
+163,470
| +56% | +$17M |
|
79
Automatic Data Processing
ADP
$122B
| $47.3M | 0.27% |
170,992
+875
| +0.5% | +$242K |
|
80
Stryker
SYK
$151B
| $46.6M | 0.27% |
128,991
-22,974
| -15% | -$8.3M |
|
81
American Water Works
AWK
$27.6B
| $45.6M | 0.26% |
312,129
-49,545
| -14% | -$7.25M |
|
82
Rockwell Automation
ROK
$38.4B
| $44.8M | 0.26% |
166,830
-1,765
| -1% | -$474K |
|
83
HCA Healthcare
HCA
$96.3B
| $44.5M | 0.26% |
109,488
+18,845
| +21% | +$7.66M |
|
84
Johnson & Johnson
JNJ
$431B
| $43M | 0.25% |
265,152
-15,083
| -5% | -$2.44M |
|
85
Ameriprise Financial
AMP
$48.3B
| $42.4M | 0.24% |
90,300
-580
| -0.6% | -$272K |
|
86
McKesson
MCK
$86B
| $42.3M | 0.24% |
85,466
-1,468
| -2% | -$726K |
|
87
Ascendis Pharma
ASND
$12B
| $42.2M | 0.24% |
282,331
+86,984
| +45% | +$13M |
|
88
Bristol-Myers Squibb
BMY
$95B
| $42M | 0.24% |
811,645
+119,440
| +17% | +$6.18M |
|
89
Moderna
MRNA
$9.45B
| $41.9M | 0.24% |
627,666
+145,614
| +30% | +$9.73M |
|
90
Universal Display
OLED
$6.88B
| $41.6M | 0.24% |
197,987
-1,780
| -0.9% | -$374K |
|
91
Synopsys
SNPS
$111B
| $41.4M | 0.24% |
81,769
+18,371
| +29% | +$9.3M |
|
92
Biogen
BIIB
$20.5B
| $41.2M | 0.24% |
212,457
-54,002
| -20% | -$10.5M |
|
93
PNC Financial Services
PNC
$81.7B
| $41M | 0.24% |
221,706
+4,042
| +2% | +$747K |
|
94
Walt Disney
DIS
$214B
| $40.9M | 0.24% |
425,698
+157
| +0% | +$15.1K |
|
95
Consolidated Edison
ED
$35.3B
| $40.8M | 0.23% |
391,755
-73,771
| -16% | -$7.68M |
|
96
Equinix
EQIX
$75.2B
| $40.4M | 0.23% |
45,558
-20,435
| -31% | -$18.1M |
|
97
Ball Corp
BALL
$13.7B
| $40.4M | 0.23% |
594,541
+9,964
| +2% | +$677K |
|
98
Vertiv
VRT
$48B
| $40M | 0.23% |
402,198
+132,491
| +49% | +$13.2M |
|
99
Boston Scientific
BSX
$159B
| $39.8M | 0.23% |
474,915
+38,174
| +9% | +$3.2M |
|
100
Ultragenyx Pharmaceutical
RARE
$3.01B
| $39.6M | 0.23% |
713,092
+24,150
| +4% | +$1.34M |
|